Utilising Invariant Natural Killer T Cell Activation to Promote the Survival of Cardiac Allografts

Medicine & Life Sciences

1. Salmonella Infections 100%
2. Natural Killer T-Cells 55%
3. C-Type Lectins 54%
4. Inflammation 47%
5. Bone Marrow Cells 37%
6. Infections 33%
7. Blood Platelets 31%
8. Thrombosis 30%
9. Fats 30%
10. Stem Cells 29%
11. Thymus Gland 28%
12. Epithelial Cells 28%
13. Lymphocytes 27%
14. Phenotype 24%
15. Cell Transplantation 21%
16. T-Lymphocytes 20%
17. CD1d Antigen 19%
18. Interleukin-15 12%
19. Salmonella 12%
20. Chemokine CXCL13 11%
21. Platelet Activation 11%
22. Antigen Presentation 10%
23. Allogeneic Cells 10%
24. Leukopoiesis 10%
25. B-Lymphocytes 10%
26. Allografts 8%
27. B-Lymphocyte Subsets 8%
28. Immune System 7%
29. Germinal Center 7%
30. Tumor Necrosis Factor Receptors 7%
31. Transplantation 7%
32. Intra-Abdominal Fat 7%
33. Pericardium 7%
34. Peritoneal Cavity 7%
35. Lymphoid Tissue 7%
36. Healthy Aging 7%
37. Myeloid Cells 6%
38. Bacteria 6%
39. Stromal Cells 6%
40. Cytokines 6%
41. Kupffer Cells 6%
42. Cell Lineage 6%
43. Salmonella typhimurium 5%
44. Autoimmunity 5%
45. Thymocytes 5%
46. T-Lymphocyte Subsets 5%
47. Liver 5%
48. Bacteremia 5%
49. Adaptive Immunity 5%